Dow Inc./ US2605571031 /
22/05/2024 17:42:33 | Chg. -1.0200 | Volume | Bid18:07:15 | Ask18:07:15 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
53.2900EUR | -1.88% | 54 Turnover: 2,876.6400 |
53.1500Bid Size: 400 | 53.2000Ask Size: 400 | 37.43 bill.EUR | - | - |
GlobeNewswire
13/02
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
22/01
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
16/11/2023
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
11/10/2023
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
06/09/2023
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
17/11/2021
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year